On Monday, Catalent Inc. (NYSE: CTLT) opened higher 0.33% from the last session, before settling in for the closing price of $60.45. Price fluctuations for CTLT have ranged from $31.80 to $61.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.75% annually for the last half of the decade. Company’s average yearly earnings per share was noted 365.54% at the time writing. With a float of $177.91 million, this company’s outstanding shares have now reached $181.00 million.
In an organization with 16900 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 22.03%, operating margin of -13.88%, and the pretax margin is -23.65%.
Catalent Inc. (CTLT) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Catalent Inc. is 1.96%, while institutional ownership is 91.73%. The most recent insider transaction that took place on Sep 26 ’24, was worth 119,580. In this transaction Group President, Biologics of this company sold 1,994 shares at a rate of $59.97, taking the stock ownership to the 36,304 shares. Before that another transaction happened on Sep 26 ’24, when Company’s Officer proposed sale 2,168 for $59.98, making the entire transaction worth $130,026.
Catalent Inc. (CTLT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.14) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 365.54% per share during the next fiscal year.
Catalent Inc. (NYSE: CTLT) Trading Performance Indicators
Check out the current performance indicators for Catalent Inc. (CTLT). In the past quarter, the stock posted a quick ratio of 1.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.75, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 1.82 in one year’s time.
Technical Analysis of Catalent Inc. (CTLT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.28 million. That was inferior than the volume of 2.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 58.01%. Additionally, its Average True Range was 0.39.
During the past 100 days, Catalent Inc.’s (CTLT) raw stochastic average was set at 92.85%, which indicates a significant increase from 71.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.21% in the past 14 days, which was lower than the 9.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $60.03, while its 200-day Moving Average is $56.51. However, in the short run, Catalent Inc.’s stock first resistance to watch stands at $60.75. Second resistance stands at $60.86. The third major resistance level sits at $60.98. If the price goes on to break the first support level at $60.52, it is likely to go to the next support level at $60.40. Assuming the price breaks the second support level, the third support level stands at $60.29.
Catalent Inc. (NYSE: CTLT) Key Stats
There are currently 180,980K shares outstanding in the company with a market cap of 11.01 billion. Presently, the company’s annual sales total 4,381 M according to its annual income of -1,043 M. Last quarter, the company’s sales amounted to 1,301 M and its income totaled 23,000 K.
